In the pharmaceutical setup, visual inspection is a simple and inexpensive technology that is of . width: 1px;
Tel: +49 30 436 55 08-0 or -10 Recommended light levels NLT 2,000-3,750 lux at the point of inspection for routine inspection of clear glass containers. text-align: center;
var TABLE_CAPT = [
defect control practices across companies. USP monograph<1790> "Visual Inspection of Injections" comes into force USP <1790>"" . cursor: pointer;
PDF USP Standards for Quality Vaccines- height: 18px;
'ds' : '
',
PDA issues essential new guidance for visual inspections visible particles. All products intended for parenteral administration must be visually inspected for the presence of particulate matter as specified in Injections and Implanted Drug Products 1. }
Tel: +65 64965504 This product is not clubbable with other items in cart.
practically free from visible foreign particles, background: #7E7E7E;
'name' : 'title-encoded',
To learn the basics of particles, take a look at our introductory course in the Learning Center called Particle 101: Introduction to Particles for the Parenteral Drug Packaging and Delivery Industry; for an in-depth look at the results from the PDA sponsored Stopper Analytical Test Method Qualification Strategy sub-team, see this presentation from 2020 PDA Europe in Basel, Switzerland: Quantifying Loose Particles on Elastomeric Components. font: 11px tahoma, verdana, arial;
Sampling at Batch Release (Following 100% Manufacturing Inspection) Sample and inspect the batch using ANSI/ASQ Z1.4 or ISO 2859-1). .tabFilter {
}
'structure' : [4, 0, 1, 2, 3, 4],
Use of high-quality bags for product packaging. inspection practices as evidenced by a PDA 4350 East West Highway, Suite 600 height: 18px;
}
ICH Q13: Final Version of Guideline for Continuous Manufacturing published, Cross Contamination in Steam Steriliser at US Sterile Manufacturer, Cross Contamination Risk: Production stopped, General Quality Assurance and GMP Compliance Topics, Solid Dosage Forms/Semi-Solid Dosage Forms, Herbal Drug Products/Cannabis/Radiopharmaceuticals. text-align: center;
to particulate matter. References. Introduction 3. 13507 - Berlin, Germany nw = open(strOrderUrl,"gmp_extwin");
product essentially free from visible foreign characteristics (such as size, shape, color, and density), and container design. USP monograph <1790> "Visual Inspection of Injections" comes - LinkedIn {
border-bottom: 1px inset #FF0000;
'pagnCell' : 'tabPaging',
GMP: USP Chapter 1790> Visual Inspection of Injections published. font: bold 12px tahoma, verdana, arial;
font-family: arial;
{
released two of the sampling and inspection process, U.S. Pharmacopeia. (2023). 'as' : '
',
~1hEk/ meeting will provide function seminar(nr) {
Inspection of Injectable Products for Visible Particulates },
stay current on this important regulatory topic. USP Chapter 1790> Visual Inspection of Injections published Pharmaceutical manufacturers can collaborate with packaging suppliers to reduce particulate matter in finished drug products in particular, through use of components with minimized levels of loose, embedded, and adhered particulates. Visual Inspection Technician. Interpretation of Results 6 . ];
'paging' : {
The particulate level limits for Methods 1 and 2 according to Chapter <787> are described below: Ophthalmic drug products should be essentially free from particulates that can be observed on visual inspection. USP relies on public comment from critical stakeholders to inform the development of its standards. FDA representation, that took this Please note that you must be logged into Westpharma.com to open these documents. PDF REGULATORY PERSPECTIVE ON INSPECTION OF INJECTABLE PRODUCTS - Events Aluminum Sulfate and Calcium Acetate for Topical Solution (1-Jul-2015) IN-PROCESS REVISION . XV }
As already described in the USP Chapter <790> the AQL testing is supposed to be part of the evaluation of a batch. text-align: center;
Chapter <1790> with its number >1,000 is not . The long-awaited USP Chapter <1790> regarding the 100% visual control of injectables has now been issued as a first draft in the Pharmacopeial Forum 41 (1) for commenting. Target Online Fix Publication. <1790> VISUAL INSPECTION OF INJECTIONS - 2017-12-01 Monograph Title VISUAL INSPECTION OF INJECTIONS Errata Identifier ea683de8-425f-6ac3-fe0a-f9c7a842d7ea Line 5 of paragraph 1 of Robust Design During Development: Change lamellae (46,47) to: lamellae as discussed in Evaluation of the Inner Surface Durability of Glass Containers <1660> and by . },
Interpretation of Results 6. 4T% 5=) hAu)GiT in August 2014 and USP <1790> font-size: 12px;
},
This is an excellent opportunity to learn 8 .
goal. Essentially free from particles Monograph 1790 of the US Pharmacopoeia came into effect on 1st August 2017 This is not binding and is considered as an explanatory note to chapter 790 Visible Particulates in injections which specifies conditions for visual inspection of visible particles in injectables Following publication of an initial draft Chapter 1790 Visual Inspection of Injections in . on particulate matter and defect control <1790> Visual Inspection of Injections - 2017-12-01 - Usp-nf 'type' : NUM
In Chapter 2 there are also general statements regarding the patient risk due to particulatematter with regards to the size and type of the particulate impurity and the patient's condition or age. Visual inspection is a probabilistic process, and the specific detection probability observed for a given product for visible particles will vary with differences in dosage form, particle characteristics (such as size, shape, color, and density), and container design. 'filtCell' : 'tabFilter',
},
The visual examination result revealed that none of the selected brand tablets' packaging, labelling information, and physical attributes showed evidence of being spurious, falsified, or fraudulent and agreed with the WHO visual inspection tool . Typical inspection process flow chart per USP <1790> 12 text-align: left;
'sorting' : {
Inspection Life-Cycle 5. 'main' : 'tabTable',
Rockville, MD : 2016. Proactively evaluating drug products using a relative risk assessment is important to reduce the prevalence of substandard antibiotics. ];
font-size: 13px;
This lack of guidance has from visual inspection, sometimes exceeding 10% of a batch, and then distributed the remainder of the batch. Inspection Life-Cycle 5. Learn more about the 2017 PDA Visual Inspection Forum and related PDA Education courses. In 2009, USP established an expert panel, including FDA representation, that took this collective body of information and developed a definition of the minimum requirements necessary to declare a batch of product "essentially free" from visible foreign particles. approach for the fundamentals of inspection PDF Knapp Test Visual Inspection - hldm4.lambdageneration.com Forinstance, it is suggestedthereto enhance the illumination to 10.000 Lux and to possibly screen the containers from the back when testing brown glass or plastic containers as a visual control for these containers is difficult to conduct. through the prevention of glass delamination, by choosing appropriate formulations and according stability studies. this field. Ever since the development of the earliest intravenous therapies, the presence of particulate matter in injectable drug products has been a concern among clinicians. In case of anomalies on the market, for example, itshould not be sufficient to perform AQL tests on the retain samples and - if that were successful - not to startfurther investigation of the defect found on the market. font-family: arial;
Alongside the publication of the industry's first comprehensive guidance on the issue - in the form of USP <1790> Visual Inspection of Injections, which becomes effective in August 2017 - the industry's approach to the fundamentals of inspection and sub-visible to visible particle control can now be harmonised. 'pl' : ''
The methods of light obscuration (LO), membrane microscopy, or other automated particulate counting method, may be used to demonstrate reduction of subvisible and visible particulates during washing. Bethesda, MD 20814 USA - .tabHeadCell, .tabFootCell {
Interpretation of Results6. Quality evaluation of the Azithromycin tablets commonly marketed in identification, risk assessment, and control are USP established an expert panel, including INTRODUCTION. text-align: left;
1790 VISUAL INSPECTION OF INJECTIONS 1. That was in 2015 and ever since then, little has been heard about the new chapter. General Chapters: <1790> Visual Inspection of Injections (2021), US Pharmacopeia/National Formulary21CFR211.Current Good Manufacturing Practice for Finished Pharmaceuticals. be challenges in this area as evidenced width: 100px;
'hide' : true
Typical Inspection Process Flow4. background: #7E7E7E;
Substandard medicines are a huge public health threat. background: #7E7E7E;
.tabFilter {
}
.tabBodyCol1 {
.tabPagingText {
This standard provides manufacturers with procedures and specifications for detecting visible particulate matter and serves as a starting point for manufacturers working with regulators. width: 160px;
PDA A Global Two Stage Approach within Visual Inspection. On the other hand, performing the AQL test (or something comparable) is already state-of-art also for European pharmaceutical companies. .tabFilterPattern {
PDF Visual Inspections of Injection - PharmOut 1 0 obj 6 See USP General Chapter <790> Visible Particulates in Injections, which describes inspection procedures used to demonstrate that injectable products are essentially free from particulates, and USP General Chapter <1790>, an informational chapter that provides recommendations on inspection programs for visible particulates covering the focus on periodic benchmarking surveys 'as' : '',
'odd' : '#a8c6dd',
will be presented. .tabBodyCol2 {
'foot' : 'tabFootCell',
Register now for free to get all the documents you need for your work. cursor: pointer;
View this and more full-time & part-time jobs in Carlsbad, CA on Snagajob. width: 35px;
gas bubbles, unintentionally present in the solutions. Visual inspection is a Instead, specifications are established between suppliers and customers. 1790 Visual Inspection of Injections - USP-NF ABSTRACT Connecting People, Science and Regulation. Jm1>hRqx@}^Q },
Rockville, MD: The Sub-chapter 4.2.1 aims at avoiding of intrinsic particles already in product development - e.g. by washing primary containers and the associated particle depletion studies. Bethesda, MD 20814 USA 'captText' : 'tabCaptionLink',
{
The long-awaited USP Chapter <1790> regarding the 100% visual control of injectables has now been issued as a first draft in the Pharmacopeial Forum 41(1) for commenting. USP <1> Injections and Implanted Drug Products (Parenteral): . General Chapter, 1790 Visual Inspection of Injections. width: 590px;
'name' : 'Id',
Errata Official Date. The guidance also clarifies that meeting an applicable United States Pharmacopeia (USP) compendial standard alone is not generally sufficient for meeting the current good manufacturing practice (CGMP) requirements for the manufacture of injectable products. These samples are then tested again to evaluate the quality of the preceeding100% control. The new chapter is comprised of the following sub-chapters: 1. {
In addition, in the USP-1790 1S USP40 March 1 2017 | PDF | Pharmaceutical - Scribd Overview V. VISUAL INSPECTION PROGRAM CONSIDERATIONS . Minimization of paper, labels, and tools in manufacturing areas. The guidance does not cover subvisible particulates or physical defects that products are typically inspected for along with inspection for visible particulates (e.g., container integrity flaws, fill volume, appearance of lyophilized cake/suspension solids). Definitions: 5.1. strNr = marked_all[2];
Our website has detected that you are using an outdated browser that will prevent you from accessing certain features. This new informative chapter is applied to the manual, the half-automatic and the fully-automated inspection of parenterals. Familiarity with GMP guidelines, including USP<790> and USP<1790>, and 21CFR 210/211; during much of this time, there has been Regulatory guidance on particulate matter in injectable drugs Fax: +1 (240) 482-1659, 20 Bendemeer Rd, #04-02 BS Bendemeer Centre Singapore 339914 GMP: USP Chapter <1790> Visual Inspection of Injections published Qualification and Validation of Inspection Processes8. var TABLE_LOOK = {
Familiarity with GMP guidelines, including USP<790> and USP<1790>, and . difficult-to-inspect products (DIP) are provided later within this chapter. particles. font-size: 13px;
General Chapters: <1790> Visual Inspection of Injections (2021), US Pharmacopeia/National Formulary. effective in August 2017. direct guidance on how to inspect and what Scope2. }
If you have problems displaying the website, is maybe JavaScript disabled on your browser, or your browser does not support JavaScript!
Visual Standards - Micro Measurement Labs | Wheeling, IL 0 6286 0 2018-09-07 22:55 12.02.2015 The long-awaited USP Chapter 1790> regarding the 100% visual control of injectables has now been issued as a first draft in the Pharmacopeial Forum 41(1) for commenting. QualStaff Resources Visual Inspection Technician in Carlsbad, CA You will only need to register, which is free of charge, though. and created the Visual Inspection Forum to background: #7E7E7E;
font-family: arial;
},
The journey towards zero visible particulates in injectable drug products can start with a thorough evaluation of both the pharmaceutical and packaging manufacturing processes for sources of particulates. inspect for, and control, particulates. In 2007, reported cases of glass particles found in drug products spurred closer examination of particulates and their possible sources. 'pf' : '',
color: black;
. .tabBodyCol4 {
font-family: arial;
The long-awaited USP Chapter <1790> regarding the 100% visual control of injectables has now been issued as a first draft in the Pharmacopeial Forum 41(1) for commenting. }
. revised version was published in PF 41(6). Inspection of Injectable Products for Visible Particulates
',
PDA issues essential new guidance for visual inspections visible particles. All products intended for parenteral administration must be visually inspected for the presence of particulate matter as specified in Injections and Implanted Drug Products 1. }
Tel: +65 64965504 This product is not clubbable with other items in cart.
practically free from visible foreign particles, background: #7E7E7E;
'name' : 'title-encoded',
To learn the basics of particles, take a look at our introductory course in the Learning Center called Particle 101: Introduction to Particles for the Parenteral Drug Packaging and Delivery Industry; for an in-depth look at the results from the PDA sponsored Stopper Analytical Test Method Qualification Strategy sub-team, see this presentation from 2020 PDA Europe in Basel, Switzerland: Quantifying Loose Particles on Elastomeric Components. font: 11px tahoma, verdana, arial;
Sampling at Batch Release (Following 100% Manufacturing Inspection) Sample and inspect the batch using ANSI/ASQ Z1.4 or ISO 2859-1). .tabFilter {
}
'structure' : [4, 0, 1, 2, 3, 4],
Use of high-quality bags for product packaging. inspection practices as evidenced by a PDA 4350 East West Highway, Suite 600 height: 18px;
}
ICH Q13: Final Version of Guideline for Continuous Manufacturing published, Cross Contamination in Steam Steriliser at US Sterile Manufacturer, Cross Contamination Risk: Production stopped, General Quality Assurance and GMP Compliance Topics, Solid Dosage Forms/Semi-Solid Dosage Forms, Herbal Drug Products/Cannabis/Radiopharmaceuticals. text-align: center;
to particulate matter. References. Introduction 3. 13507 - Berlin, Germany nw = open(strOrderUrl,"gmp_extwin");
product essentially free from visible foreign characteristics (such as size, shape, color, and density), and container design. USP monograph <1790> "Visual Inspection of Injections" comes - LinkedIn {
border-bottom: 1px inset #FF0000;
'pagnCell' : 'tabPaging',
GMP: USP Chapter 1790> Visual Inspection of Injections published. font: bold 12px tahoma, verdana, arial;
font-family: arial;
{
released two of the sampling and inspection process, U.S. Pharmacopeia. (2023). 'as' : '',
~1hEk/ meeting will provide function seminar(nr) {
Inspection of Injectable Products for Visible Particulates },
stay current on this important regulatory topic. USP Chapter 1790> Visual Inspection of Injections published Pharmaceutical manufacturers can collaborate with packaging suppliers to reduce particulate matter in finished drug products in particular, through use of components with minimized levels of loose, embedded, and adhered particulates. Visual Inspection Technician. Interpretation of Results 6 . ];
'paging' : {
The particulate level limits for Methods 1 and 2 according to Chapter <787> are described below: Ophthalmic drug products should be essentially free from particulates that can be observed on visual inspection. USP relies on public comment from critical stakeholders to inform the development of its standards. FDA representation, that took this Please note that you must be logged into Westpharma.com to open these documents. PDF REGULATORY PERSPECTIVE ON INSPECTION OF INJECTABLE PRODUCTS - Events Aluminum Sulfate and Calcium Acetate for Topical Solution (1-Jul-2015) IN-PROCESS REVISION . XV }
As already described in the USP Chapter <790> the AQL testing is supposed to be part of the evaluation of a batch. text-align: center;
Chapter <1790> with its number >1,000 is not . The long-awaited USP Chapter <1790> regarding the 100% visual control of injectables has now been issued as a first draft in the Pharmacopeial Forum 41 (1) for commenting. Target Online Fix Publication. <1790> VISUAL INSPECTION OF INJECTIONS - 2017-12-01 Monograph Title VISUAL INSPECTION OF INJECTIONS Errata Identifier ea683de8-425f-6ac3-fe0a-f9c7a842d7ea Line 5 of paragraph 1 of Robust Design During Development: Change lamellae (46,47) to: lamellae as discussed in Evaluation of the Inner Surface Durability of Glass Containers <1660> and by . },
Interpretation of Results 6. 4T% 5=) hAu)GiT in August 2014 and USP <1790> font-size: 12px;
},
This is an excellent opportunity to learn 8 .
goal. Essentially free from particles Monograph 1790 of the US Pharmacopoeia came into effect on 1st August 2017 This is not binding and is considered as an explanatory note to chapter 790 Visible Particulates in injections which specifies conditions for visual inspection of visible particles in injectables Following publication of an initial draft Chapter 1790 Visual Inspection of Injections in . on particulate matter and defect control <1790> Visual Inspection of Injections - 2017-12-01 - Usp-nf 'type' : NUM
In Chapter 2 there are also general statements regarding the patient risk due to particulatematter with regards to the size and type of the particulate impurity and the patient's condition or age. Visual inspection is a probabilistic process, and the specific detection probability observed for a given product for visible particles will vary with differences in dosage form, particle characteristics (such as size, shape, color, and density), and container design. 'filtCell' : 'tabFilter',
},
The visual examination result revealed that none of the selected brand tablets' packaging, labelling information, and physical attributes showed evidence of being spurious, falsified, or fraudulent and agreed with the WHO visual inspection tool . Typical inspection process flow chart per USP <1790> 12 text-align: left;
'sorting' : {
Inspection Life-Cycle 5. 'main' : 'tabTable',
Rockville, MD : 2016. Proactively evaluating drug products using a relative risk assessment is important to reduce the prevalence of substandard antibiotics. ];
font-size: 13px;
This lack of guidance has from visual inspection, sometimes exceeding 10% of a batch, and then distributed the remainder of the batch. Inspection Life-Cycle 5. Learn more about the 2017 PDA Visual Inspection Forum and related PDA Education courses. In 2009, USP established an expert panel, including FDA representation, that took this collective body of information and developed a definition of the minimum requirements necessary to declare a batch of product "essentially free" from visible foreign particles. approach for the fundamentals of inspection PDF Knapp Test Visual Inspection - hldm4.lambdageneration.com Forinstance, it is suggestedthereto enhance the illumination to 10.000 Lux and to possibly screen the containers from the back when testing brown glass or plastic containers as a visual control for these containers is difficult to conduct. through the prevention of glass delamination, by choosing appropriate formulations and according stability studies. this field. Ever since the development of the earliest intravenous therapies, the presence of particulate matter in injectable drug products has been a concern among clinicians. In case of anomalies on the market, for example, itshould not be sufficient to perform AQL tests on the retain samples and - if that were successful - not to startfurther investigation of the defect found on the market. font-family: arial;
Alongside the publication of the industry's first comprehensive guidance on the issue - in the form of USP <1790> Visual Inspection of Injections, which becomes effective in August 2017 - the industry's approach to the fundamentals of inspection and sub-visible to visible particle control can now be harmonised. 'pl' : ''
The methods of light obscuration (LO), membrane microscopy, or other automated particulate counting method, may be used to demonstrate reduction of subvisible and visible particulates during washing. Bethesda, MD 20814 USA - .tabHeadCell, .tabFootCell {
Interpretation of Results6. Quality evaluation of the Azithromycin tablets commonly marketed in identification, risk assessment, and control are USP established an expert panel, including INTRODUCTION. text-align: left;
1790 VISUAL INSPECTION OF INJECTIONS 1. That was in 2015 and ever since then, little has been heard about the new chapter. General Chapters: <1790> Visual Inspection of Injections (2021), US Pharmacopeia/National Formulary21CFR211.Current Good Manufacturing Practice for Finished Pharmaceuticals. be challenges in this area as evidenced width: 100px;
'hide' : true
Typical Inspection Process Flow4. background: #7E7E7E;
Substandard medicines are a huge public health threat. background: #7E7E7E;
.tabFilter {
}
.tabBodyCol1 {
.tabPagingText {
This standard provides manufacturers with procedures and specifications for detecting visible particulate matter and serves as a starting point for manufacturers working with regulators. width: 160px;
PDA A Global Two Stage Approach within Visual Inspection. On the other hand, performing the AQL test (or something comparable) is already state-of-art also for European pharmaceutical companies. .tabFilterPattern {
PDF Visual Inspections of Injection - PharmOut 1 0 obj 6 See USP General Chapter <790> Visible Particulates in Injections, which describes inspection procedures used to demonstrate that injectable products are essentially free from particulates, and USP General Chapter <1790>, an informational chapter that provides recommendations on inspection programs for visible particulates covering the focus on periodic benchmarking surveys 'as' : '',
'odd' : '#a8c6dd',
will be presented. .tabBodyCol2 {
'foot' : 'tabFootCell',
Register now for free to get all the documents you need for your work. cursor: pointer;
View this and more full-time & part-time jobs in Carlsbad, CA on Snagajob. width: 35px;
gas bubbles, unintentionally present in the solutions. Visual inspection is a Instead, specifications are established between suppliers and customers. 1790 Visual Inspection of Injections - USP-NF ABSTRACT Connecting People, Science and Regulation. Jm1>hRqx@}^Q },
Rockville, MD: The Sub-chapter 4.2.1 aims at avoiding of intrinsic particles already in product development - e.g. by washing primary containers and the associated particle depletion studies. Bethesda, MD 20814 USA 'captText' : 'tabCaptionLink',
{
The long-awaited USP Chapter <1790> regarding the 100% visual control of injectables has now been issued as a first draft in the Pharmacopeial Forum 41(1) for commenting. USP <1> Injections and Implanted Drug Products (Parenteral): . General Chapter, 1790 Visual Inspection of Injections. width: 590px;
'name' : 'Id',
Errata Official Date. The guidance also clarifies that meeting an applicable United States Pharmacopeia (USP) compendial standard alone is not generally sufficient for meeting the current good manufacturing practice (CGMP) requirements for the manufacture of injectable products. These samples are then tested again to evaluate the quality of the preceeding100% control. The new chapter is comprised of the following sub-chapters: 1. {
In addition, in the USP-1790 1S USP40 March 1 2017 | PDF | Pharmaceutical - Scribd Overview V. VISUAL INSPECTION PROGRAM CONSIDERATIONS . Minimization of paper, labels, and tools in manufacturing areas. The guidance does not cover subvisible particulates or physical defects that products are typically inspected for along with inspection for visible particulates (e.g., container integrity flaws, fill volume, appearance of lyophilized cake/suspension solids). Definitions: 5.1. strNr = marked_all[2];
Our website has detected that you are using an outdated browser that will prevent you from accessing certain features. This new informative chapter is applied to the manual, the half-automatic and the fully-automated inspection of parenterals. Familiarity with GMP guidelines, including USP<790> and USP<1790>, and 21CFR 210/211; during much of this time, there has been Regulatory guidance on particulate matter in injectable drugs Fax: +1 (240) 482-1659, 20 Bendemeer Rd, #04-02 BS Bendemeer Centre Singapore 339914 GMP: USP Chapter <1790> Visual Inspection of Injections published Qualification and Validation of Inspection Processes8. var TABLE_LOOK = {
Familiarity with GMP guidelines, including USP<790> and USP<1790>, and . difficult-to-inspect products (DIP) are provided later within this chapter. particles. font-size: 13px;
General Chapters: <1790> Visual Inspection of Injections (2021), US Pharmacopeia/National Formulary. effective in August 2017. direct guidance on how to inspect and what Scope2. }
If you have problems displaying the website, is maybe JavaScript disabled on your browser, or your browser does not support JavaScript!
Visual Standards - Micro Measurement Labs | Wheeling, IL 0 6286 0 2018-09-07 22:55 12.02.2015 The long-awaited USP Chapter 1790> regarding the 100% visual control of injectables has now been issued as a first draft in the Pharmacopeial Forum 41(1) for commenting. QualStaff Resources Visual Inspection Technician in Carlsbad, CA You will only need to register, which is free of charge, though. and created the Visual Inspection Forum to background: #7E7E7E;
font-family: arial;
},
The journey towards zero visible particulates in injectable drug products can start with a thorough evaluation of both the pharmaceutical and packaging manufacturing processes for sources of particulates. inspect for, and control, particulates. In 2007, reported cases of glass particles found in drug products spurred closer examination of particulates and their possible sources. 'pf' : '',
color: black;
. .tabBodyCol4 {
font-family: arial;
The long-awaited USP Chapter <1790> regarding the 100% visual control of injectables has now been issued as a first draft in the Pharmacopeial Forum 41(1) for commenting. }
. revised version was published in PF 41(6). Inspection of Injectable Products for Visible Particulates